🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/06/2003 | 50,31 | 52,59 | 49,82 | 51,80 | +2,90% | 5,51% | 190.997 |
| 24/06/2003 | 48,85 | 51,65 | 47,99 | 50,34 | +2,28% | 7,51% | 243.603 |
| 23/06/2003 | 50,49 | 50,79 | 47,57 | 49,22 | -1,79% | 6,38% | 437.806 |
| 20/06/2003 | 48,13 | 51,62 | 47,84 | 50,12 | +4,86% | 7,85% | 241.679 |
| 19/06/2003 | 53,75 | 54,46 | 47,35 | 47,80 | -11,44% | 13,23% | 296.929 |
| 18/06/2003 | 56,33 | 56,44 | 52,89 | 53,97 | -3,29% | 6,31% | 119.450 |
| 17/06/2003 | 56,93 | 57,08 | 55,66 | 55,81 | -1,26% | 2,50% | 181.086 |
| 16/06/2003 | 55,62 | 58,88 | 54,98 | 56,52 | +1,62% | 7,00% | 304.730 |
| 13/06/2003 | 56,67 | 57,64 | 55,02 | 55,62 | -2,17% | 4,62% | 199.921 |
| 12/06/2003 | 54,09 | 57,45 | 53,71 | 56,86 | +5,19% | 6,92% | 494.312 |
| 11/06/2003 | 50,16 | 54,42 | 50,01 | 54,05 | +7,36% | 8,81% | 524.395 |
| 10/06/2003 | 53,30 | 53,30 | 49,63 | 50,34 | -2,75% | 6,88% | 203.207 |
| 09/06/2003 | 53,90 | 54,72 | 51,02 | 51,77 | -4,95% | 6,88% | 213.306 |
| 06/06/2003 | 61,46 | 62,10 | 52,29 | 54,46 | -9,74% | 15,96% | 672.512 |
| 05/06/2003 | 53,34 | 60,64 | 53,15 | 60,34 | +13,44% | 14,04% | 835.243 |
| 04/06/2003 | 49,59 | 53,34 | 47,35 | 53,19 | +7,08% | 12,08% | 325.329 |
| 03/06/2003 | 50,90 | 51,50 | 49,15 | 49,67 | -2,78% | 4,63% | 359.072 |
| 02/06/2003 | 48,85 | 53,97 | 48,85 | 51,09 | +7,23% | 10,50% | 852.796 |
| 30/05/2003 | 46,08 | 47,76 | 45,85 | 47,65 | +3,50% | 4,14% | 628.830 |
| 29/05/2003 | 45,03 | 46,56 | 44,65 | 46,04 | +2,59% | 4,24% | 505.079 |
| 28/05/2003 | 44,43 | 45,07 | 43,98 | 44,88 | -2,68% | 2,44% | 997.627 |
| 27/05/2003 | 40,24 | 46,64 | 40,20 | 46,11 | +14,29% | 16,00% | 485.362 |
| 23/05/2003 | 38,85 | 40,57 | 38,85 | 40,35 | +3,75% | 4,43% | 272.163 |
| 22/05/2003 | 37,73 | 39,26 | 37,43 | 38,89 | +2,67% | 4,86% | 212.638 |
| 21/05/2003 | 38,81 | 38,85 | 37,24 | 37,88 | -2,69% | 4,15% | 211.863 |
| 20/05/2003 | 40,57 | 40,99 | 38,74 | 38,93 | -4,15% | 5,54% | 635.670 |
| 19/05/2003 | 39,79 | 40,80 | 38,10 | 40,61 | +1,50% | 6,77% | 317.955 |
| 16/05/2003 | 41,14 | 42,82 | 39,15 | 40,01 | -3,87% | 8,92% | 477.106 |
| 15/05/2003 | 40,57 | 42,82 | 40,39 | 41,62 | +3,44% | 6,00% | 793.859 |
| 14/05/2003 | 37,62 | 40,72 | 36,79 | 40,24 | +7,61% | 10,45% | 402.513 |